Clinical Trial

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Recruiting
View on ClinicalTrials.gov →
Summary
This is a long-term, safety and efficacy follow-up study of patients in the EXG102-031-111 gene therapy clinical trial for wAMD. Patients will complete visits from the parent study, and then into this long-term follow-up study for continuous safety monitoring for up to 5 years.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-28.
Status change: Not Yet Recruiting → Recruiting 2025-08-14
Trial Details
NCT Number NCT06859515
Lead Sponsor Guangzhou Jiayin Biotech Ltd
Collaborators: Peking University People's Hospital
Conditions Wet Age-related Macular Degeneration
Enrollment 42 participants
Start Date 2025-03-13
Primary Completion 2030-05-15 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-15